Healthcare Equipment and Supplies
Company Overview of Akonni Biosystems, Inc.
Akonni Biosystems, Inc., a molecular diagnostics company, develops, manufactures, and markets integrated molecular diagnostic systems for clinical and life science research markets. The company offers TruDiagnosis, a point-of-care molecular testing platform that enables physicians or lab technicians to analyze infectious diseases. Its products include TruTip kits for DNA/RNA extraction and purification; TruArray tests that provide multiplexed molecular diagnostic (MDx) analyses starting from clinical samples, such as blood, saliva, or urine; and MDx instrument platforms, including microarray readers, thermal cyclers, and software. The company’s products are used in the diagnosis of infectiou...
400 Sagner Avenue
Frederick, MD 21701
Founded in 2003
Key Executives for Akonni Biosystems, Inc.
Founder, Chief Executive Officer, President and Director
Vice President of Operations
Director of Application Development
Compensation as of Fiscal Year 2017.
Akonni Biosystems, Inc. Key Developments
Akonni Biosystems, Inc. Presents at 24th Annual NewsMakers in the Biotech Industry, Sep-08-2017 11:15 AM
Aug 30 17
Akonni Biosystems, Inc. Presents at 24th Annual NewsMakers in the Biotech Industry, Sep-08-2017 11:15 AM. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States.
Akonni Biosystems Secures NIH Contract to Develop Non-Invasive Rapid Diagnostic for Lower Respiratory Diseases in Children
Aug 10 17
Akonni Biosystems reported the receipt of a Phase 1 Small Business Innovation Research (SBIR) contract to accelerate the advancement of its proprietary technologies to address the critically unmet need for simple affordable tools to diagnose lower respiratory diseases in children. This SBIR contract was awarded by the National Institute of Allergy and Infectious Diseases part of the National Institutes of Health (NIH) in the Department of Health and Human Services.
Akonni Biosystems Elects Brian J. Morra as Executive Chairman of the Board
Jun 27 17
Akonni Biosystems, Inc. announced the election of Mr. Brian J. Morra as the company's Executive Chairman of the Board of Directors. His election highlights the company's commitment to succeeding in the next phase of its corporate development. In his new role, Mr. Morra will lead the Board of Directors and provide crucial operational support to Akonni's Founder and CEO, Dr. Charles Daitch. He will work closely with the Board, senior management, and other key stakeholders to ensure the company's financial and operational posture enables it to meet its strategic corporate objectives and build shareholder value. Mr. Morra was a senior executive in two entrepreneurial firms that each had highly successful liquidity events. As a senior vice president at Pacific-Sierra Research Corporation (PSR) he was instrumental in the company's successful all-cash sale to Veridian. As a sector president at Veridian, Mr. Morra was an integral player in the company's M&A strategy, culminating in several acquisitions and their integration into the firm. Veridian subsequently conducted a successful IPO in 2002 and was acquired by General Dynamics in 2003. Daitch worked for and was mentored by Morra at PSR and Veridian. Daitch's biological detection business unit played a key role in the acquisition of PSR by Veridian for $55 million in 1998 and became one of the 5 key pillars to Veridian's successful 2002 IPO raising $213 million (market cap $495 million).
Similar Private Companies By Industry
Recent Private Companies Transactions
January 20, 2018
August 22, 2017
March 15, 2017